Hazel Maridith Barlahan Biag
Overview
Explore the profile of Hazel Maridith Barlahan Biag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proteau-Lemieux M, Knoth I, Davoudi S, Martin C, Belanger A, Fontaine V, et al.
J Neurodev Disord
. 2024 Sep;
16(1):53.
PMID: 39251926
Background: Fragile X syndrome (FXS) and autism spectrum disorder (ASD) are neurodevelopmental conditions that often have a substantial impact on daily functioning and quality of life. FXS is the most...
2.
Seng P, Montanaro F, Biag H, Salcedo-Arellano M, Kim K, Ponzini M, et al.
Front Psychol
. 2024 Jun;
15:1305597.
PMID: 38939222
Introduction: Metformin has been used as a targeted treatment to potentially improve cognition and slow the typical IQ decline that occurs during development among individuals with fragile X syndrome (FXS)....
3.
Aishworiya R, Tak Y, Ponzini M, Biag H, Salcedo-Arellano M, Kim K, et al.
Int J Dev Neurosci
. 2023 Sep;
83(8):715-727.
PMID: 37724826
This study aimed to determine the association between severity of autism spectrum disorder (ASD) and cognitive, behavioral, and molecular measures in individuals with fragile X syndrome (FXS). Study inclusion criteria...
4.
Aishworiya R, Biag H, Salcedo-Arellano M, Musa Z, Schneider A, Clark C, et al.
J Dev Behav Pediatr
. 2023 Aug;
44(7):e470-e475.
PMID: 37556593
Background: Fragile X syndrome (FXS) and fetal alcohol syndrome disorders are both common causes of intellectual disability in children. When both conditions are present in the same individual, the resultant...
5.
Aishworiya R, Chi M, Zafarullah M, Mendoza G, Ponzini M, Kim K, et al.
Cells
. 2023 Jul;
12(14).
PMID: 37508583
This study contributes to a greater understanding of the utility of molecular biomarkers to identify clinical phenotypes of fragile X syndrome (FXS). Correlations of baseline clinical trial data (molecular measures-...
6.
Proteau-Lemieux M, Knoth I, Agbogba K, Cote V, Biag H, Thurman A, et al.
Front Psychiatry
. 2022 Mar;
13:867000.
PMID: 35280176
[This corrects the article DOI: 10.3389/fpsyt.2021.716707.].
7.
Proteau-Lemieux M, Knoth I, Agbogba K, Cote V, Biag H, Thurman A, et al.
Front Psychiatry
. 2021 Dec;
12:716707.
PMID: 34858220
Fragile X syndrome (FXS) is a genetic disorder caused by a mutation of the (). FXS is associated with neurophysiological abnormalities, including cortical hyperexcitability. Alterations in electroencephalogram (EEG) resting-state power...
8.
Rajaratnam A, Potter L, Biag H, Schneider A, Petrasic I, Hagerman R
Front Neurol
. 2020 Nov;
11:581429.
PMID: 33193037
Given significant genetic, molecular, and phenotypic overlaps, researchers have begun to investigate whether targeted treatments for Fragile X Syndrome (FXS) could also be beneficial for patients with Autism Spectrum Disorder...